GBA Presents: RADIO SAVANT-!

  1. #2241 Jun 13, 2022 Report
    Reply Share

  2. stonedinvestor Dear Children This is the bottom for PLTR

    Papa says they they are bidding on a huge NHS contract in England.

    BUY 1000 PLTR! :fistbump:

    Palantir Technologies call volume above normal and directionally bullish 11:25 PLTR Bullish option flow…

    #2242 Jun 13, 2022 Report
    Reply Share

  3. stonedinvestor GBA Upgrade To Buy from Sell- Palantir Technologies Inc. (PLTR)
    NYSE - Nasdaq Real Time Price.
    7.58-0.68 (-8.23%)<---- all day
    As of 11:27AM EDT.


GBA->OUT PLTR $`10.09<-------------:thumbsup:
 
--UPDATE-- 3 sells

RADIO SAVANT PORTFOLIO- GBA Buys- :caution:

1- PLTR- $7.50-------> $8.04--> $8.24 XXXXXXXXXXXXX SOLD $10.09

2- Coca Cola- $61.00--> $59---> $62.87

3- Nutrian- $84.25--------> $87---->$83! ---->$80<-------- :mad:


4- FORMULA 1-- $55.85 FWONA---> $57.81

5- XXII--- $1.78 XXXXXXXXXXXXXX SOLD $2.45

6- NIO $18.58 ------------> $20.77 XXXXXXXXXXXXXXXX SOLD $24

7- Boston Scientific $36.10---> $37.94

8- Next Era ENERGY - $76.50 (VAN)---> $78.00
 
Last edited:
The company has a stellar balance sheet, with almost $1 billion in cash and zero debt. This has been achieved in part by the fact that this company loves to print out free cash flow, with over $300m in FCF achieved in both 2020 and 2021. Given the growth that lies ahead of this company, I think it could become a cash generating machine.

The company is TradeDesk.
 
B>R>E>A>K>I>N>G-!

ESPN renews Formula One rights, beating Amazon, Comcast, Netflix - report :p -
ESPN renews Formula One rights, beating Amazon, Comcast, Netflix - report

Jun. 24, 2022 3:49 PM ETThe Walt Disney Company (DIS),FWONAAMZN,CMCSA,NFLX,FWONB,FWONK
image_533452776.jpg


  • Formula One Racing (NASDAQ:FWONA) has agreed torenewits broadcast rights deal with ESPN (NYSE:DIS) through 2025, Sports Business Journal reports.
  • That contract's not signed yet, according to the report, but rival bidders Amazon.com (AMZN) and Comcast (CMCSA) have been informed that their bids won't be accepted.
  • And the three-year deal reportedly comes at $75M-$90M per year - :wtf::wtf::wtf::wtf:a sharp increase from the $5M per year ESPN had in a three-year, $15M deal from 2019 (but apparently below an Amazon.com bid of around $100M per year and a similar bid from Comcast). Netflix (NFLX), which has seen racing success with its Drive to Survive docuseries, put in a bid that wasn't close on the money, SBJ said.
  • That may have come down to streaming rights requested. For Disney's (DIS) part, while most races will be carried on its ABC or ESPN linear channels, ESPN has the flexibility to put a small number on its ESPN+ streaming service, according to SBJ.


 
Northland 'confidently reiterating' Agilysys as top pick after meetings » 09:01 AGYS

5/18 <-- 1 month ago.
Agilysys price target raised to $50 from $45 at Craig-Hallum 05/18 AGYS, ORCL Craig-Hallum analyst George Sutton raised the firm's price target on Agilysys (AGYS) to $50 from $45 and keeps a Buy rating on the shares following quarterly results. Following a few years of heavy R&D investment, the company is clearly demonstrating that it has outmaneuvered its largest competitor in hospitality software, Oracle (ORCL), who barely addresses the business unit on its earnings calls, the analyst notes. Sutton also likes the company's position against its macro-environment, where five out of the seven key verticals are still in recovery, providing incremental upside potential.

GBA UPGRADE TO BUY- AGYS $39.50


Roth says timing of FDA nicotine decision 'couldn't be better' for 22nd Century 08:34 XXII Roth Capital analyst Brian Wright notes the FDA officially announced it will be pursuing a maximum nicotine content level in all cigarettes sold in the United States. While this is an early step in a multi-year process with the proposed rule not expected until May 2023, the timing of the decision couldn't be better for 22nd Century's launch of its 95% reduced nicotine content cigarettes, the analyst contends. These are the only FDA-approved minimum nicotine content cigarettes on the market, he adds. Wright reiterates a Buy rating on 22nd Century's shares with a price target of $6.




NOW $43!!!!!!!
 
Hey Stoney, I have a stock for you I don't think you've ever covered.
It's a pretty low volume one, and I have never heard of it, but I was going through upgrades yesterday and this one caught my eye. Probably because I have never heard of it.
It looks solid, pricey of course, but its in your wheelhouse.

VIVO>>> $27.11
Merridian Bioscience

Check it out.
The chart looks good.
I am skeptical of upgrades though.
They have such a good track record in the last 6 months. :rolleyes:


NOW $30! // demand for reagents is huge lacking china product but why are sales not down now with Covid retreating and much less testing? This would seem to be a very dangerous set up. However There Is a Monkeypox angle<-------------



 
Back
Top